Key statistics
As of last trade, Eupraxia Pharmaceuticals Inc (EPRX:TOR) traded at 4.49, 46.25% above the 52 week low of 3.07 set on Oct 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.50 |
---|---|
High | 4.50 |
Low | 4.49 |
Bid | 4.34 |
Offer | 4.46 |
Previous close | 4.40 |
Average volume | 93.22k |
---|---|
Shares outstanding | 35.62m |
Free float | 31.66m |
P/E (TTM) | -- |
Market cap | 156.74m CAD |
EPS (TTM) | -1.40 CAD |
Data delayed at least 15 minutes, as of Nov 11 2024 14:30 GMT.
More ▼
- Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million
- Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024
- Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis
- Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024
- Eupraxia Pharmaceuticals Strengthens Senior Management Team
- Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
- Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
- Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
More ▼